Loading…
Prandial Insulin·Endocrinology - Insulins & Injectables
Glycemic control at mealtimes in Type 1 and Type 2 DM
No source link confirmed for this record yet. Its own source notes are under Additional.
Max Dose
Titrated
Onset
10-20 mins
High risk: Hypoglycemia
HIGH RISK
Timing
WITH MEALS
Avoid / Cautions
During active hypoglycemia. Patient refusing to eat. Pregnancy Category A. Widely used in gestational diabetes.
Overview
Ultra-rapid-acting mealtime (prandial) insulin. Designed to perfectly mimic the physiological burst of insulin a healthy pancreas releases when food hits the stomach.
Clinical Focus
Must be given immediately before eating. If the patient is injected and then the meal is delayed, they will suffer a severe hypoglycemic crash.
Bottom Line
Insulin aspart is a rapid-acting mealtime insulin for prandial glucose control and insulin pump therapy, but requires carbohydrate counting skill and carries significant hypoglycaemia risk if mistimed.
Brand Names
NovoRapid, Fiasp (ultra-fast)
Parenteral
Pre-filled pens or cartridges for SC injection (100 U/mL). Clear solution.
Prescribing & PBS
Authority Required (PBS).
Primary
Glycemic control at mealtimes in Type 1 and Type 2 DM. Correction of acute hyperglycemia.
Clinical Place
The 'Bolus' in the basal-bolus regimen.
No calculator, monitoring schedule or factsheet is linked to this medicine page yet.